Pages that link to "Q43209404"
Jump to navigation
Jump to search
The following pages link to Frequency and clinical consequences associated with sidebranch occlusion during stent implantation using zotarolimus-eluting and paclitaxel-eluting coronary stents (Q43209404):
Displaying 12 items.
- The molecular mechanisms of congenital hypofibrinogenaemia (Q35805441) (← links)
- Automated surveillance to detect postprocedure safety signals of approved cardiovascular devices (Q37458616) (← links)
- Very long stent technology: clinical and practical value (Q38135889) (← links)
- Second- and third-generation drug-eluting coronary stents: progress and safety (Q39759032) (← links)
- Clinical outcomes following bioresorbable scaffold implantation for bifurcation lesions: Overall outcomes and comparison between provisional and planned double stenting strategy (Q40899680) (← links)
- TWENTE Study: The Real-World Endeavor Resolute Versus Xience V Drug-Eluting Stent Study in Twente: study design, rationale and objectives (Q41887707) (← links)
- Side branch occlusion with everolimus-eluting and paclitaxel-eluting stents: three-year results from the SPIRIT III randomised trial (Q42726745) (← links)
- Propensity-Matched Patient-Level Comparison of the TAXUS Liberté and TAXUS Element (ION) Paclitaxel-Eluting Stents (Q45208320) (← links)
- Three-Year Results of Safety and Efficacy of the Everolimus-Eluting Coronary Stent in Women (from the SPIRIT III Randomized Clinical Trial) (Q83264211) (← links)
- Natural History of Side Branches Jailed by Drug‐Eluting Stents (Q85058678) (← links)
- Clinical outcomes of different first- and second-generation drug-eluting stents in routine clinical practice: results from the prospective multicenter German DES.DE registry (Q86070116) (← links)
- The Role of Bioresorbable Scaffolds in Meeting the Challenges of Bifurcations (Q88195963) (← links)